Literature DB >> 33507962

Modeling the relative risk of SARS-CoV-2 infection to inform risk-cost-benefit analyses of activities during the SARS-CoV-2 pandemic.

John E McCarthy1, Barry D Dewitt2, Bob A Dumas3, Myles T McCarthy4.   

Abstract

Risk-cost-benefit analysis requires the enumeration of decision alternatives, their associated outcomes, and the quantification of uncertainty. Public and private decision-making surrounding the COVID-19 pandemic must contend with uncertainty about the probability of infection during activities involving groups of people, in order to decide whether that activity is worth undertaking. We propose a model of SARS-CoV-2 infection probability that can produce estimates of relative risk of infection for diverse activities, so long as those activities meet a list of assumptions, including that they do not last longer than one day (e.g., sporting events, flights, concerts), and that the probability of infection among possible routes of infection (i.e., droplet, aerosol, fomite, and direct contact) are independent. We show how the model can be used to inform decisions facing governments and industry, such as opening stadiums or flying on airplanes; in particular, it allows for estimating the ranking of the constituent components of activities (e.g., going through a turnstile, sitting in one's seat) by their relative risk of infection, even when the probability of infection is unknown or uncertain. We prove that the model is a good approximation of a more refined model in which we assume infections come from a series of independent risks. A linearity assumption governing several potentially modifiable risks factors-such as duration of the activity, density of participants, and infectiousness of the attendees-makes interpreting and using the model straightforward, and we argue that it does so without significantly diminishing the reliability of the model.

Entities:  

Year:  2021        PMID: 33507962      PMCID: PMC7842882          DOI: 10.1371/journal.pone.0245381

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  22 in total

1.  The theory of decision making.

Authors:  W EDWARDS
Journal:  Psychol Bull       Date:  1954-07       Impact factor: 17.737

Review 2.  The realities of risk-cost-benefit analysis.

Authors:  Baruch Fischhoff
Journal:  Science       Date:  2015-10-30       Impact factor: 47.728

3.  Lorentzian-geometry-based analysis of airplane boarding policies highlights "slow passengers first" as better.

Authors:  Sveinung Erland; Jevgenijs Kaupužs; Vidar Frette; Rami Pugatch; Eitan Bachmat
Journal:  Phys Rev E       Date:  2019-12       Impact factor: 2.529

4.  Analysis of COVID-19 infection spread in Japan based on stochastic transition model.

Authors:  Kenji Karako; Peipei Song; Yu Chen; Wei Tang
Journal:  Biosci Trends       Date:  2020-03-19       Impact factor: 2.400

5.  Face masks: what the data say.

Authors:  Lynne Peeples
Journal:  Nature       Date:  2020-10       Impact factor: 49.962

6.  SARS-CoV-2: how safe is it to fly and what can be done to enhance protection?

Authors:  Anthony D Harries; Leonardo Martinez; Jeremiah M Chakaya
Journal:  Trans R Soc Trop Med Hyg       Date:  2021-01-07       Impact factor: 2.184

7.  It Is Time to Address Airborne Transmission of Coronavirus Disease 2019 (COVID-19).

Authors:  Lidia Morawska; Donald K Milton
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

8.  Doubling Time of the COVID-19 Epidemic by Province, China.

Authors:  Kamalich Muniz-Rodriguez; Gerardo Chowell; Chi-Hin Cheung; Dongyu Jia; Po-Ying Lai; Yiseul Lee; Manyun Liu; Sylvia K Ofori; Kimberlyn M Roosa; Lone Simonsen; Cecile Viboud; Isaac Chun-Hai Fung
Journal:  Emerg Infect Dis       Date:  2020-04-24       Impact factor: 6.883

9.  The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2.

Authors:  Vincent Chi-Chung Cheng; Shuk-Ching Wong; Vivien Wai-Man Chuang; Simon Yung-Chun So; Jonathan Hon-Kwan Chen; Siddharth Sridhar; Kelvin Kai-Wang To; Jasper Fuk-Woo Chan; Ivan Fan-Ngai Hung; Pak-Leung Ho; Kwok-Yung Yuen
Journal:  J Infect       Date:  2020-04-23       Impact factor: 6.072

10.  Assessment of SARS-CoV-2 Transmission on an International Flight and Among a Tourist Group.

Authors:  Sebastian Hoehl; Onur Karaca; Niko Kohmer; Sandra Westhaus; Jürgen Graf; Udo Goetsch; Sandra Ciesek
Journal:  JAMA Netw Open       Date:  2020-08-03
View more
  4 in total

1.  Assessing personal exposure to COVID-19 transmission in public indoor spaces based on fine-grained trajectory data: A simulation study.

Authors:  Pengfei Chen; Dongchu Zhang; Jianxiao Liu; Izzy Yi Jian
Journal:  Build Environ       Date:  2022-05-04       Impact factor: 7.093

2.  Repurposing FDA-approved drugs to fight COVID-19 using in silico methods: Targeting SARS-CoV-2 RdRp enzyme and host cell receptors (ACE2, CD147) through virtual screening and molecular dynamic simulations.

Authors:  Soodeh Mahdian; Mahboobeh Zarrabi; Yunes Panahi; Somayyeh Dabbagh
Journal:  Inform Med Unlocked       Date:  2021-02-25

3.  Assessment of the COVID-19 infection risk at a workplace through stochastic microexposure modeling.

Authors:  Sergey Vecherin; Derek Chang; Emily Wells; Benjamin Trump; Aaron Meyer; Jacob Desmond; Kyle Dunn; Maxim Kitsak; Igor Linkov
Journal:  J Expo Sci Environ Epidemiol       Date:  2022-01-31       Impact factor: 6.371

4.  Imagining Resilient Courts: from COVID-19 to the Future of Canada's Court System.

Authors:  David Matyas; Peter Wills; Barry Dewitt
Journal:  Can Public Policy       Date:  2022-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.